Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure.

Barth AS, Kumordzie A, Frangakis C, Margulies KB, Cappola TP, Tomaselli GF.

Circ Cardiovasc Genet. 2011 Oct;4(5):475-83. doi: 10.1161/CIRCGENETICS.110.957571. Epub 2011 Aug 9.

2.

Global gene expression profiling in the failing myocardium.

Asakura M, Kitakaze M.

Circ J. 2009 Sep;73(9):1568-76. Epub 2009 Jul 29. Review.

3.
4.

Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.

Roul D, Recchia FA.

Antioxid Redox Signal. 2015 Jun 10;22(17):1502-14. doi: 10.1089/ars.2015.6311. Epub 2015 Apr 30. Review.

5.

The cellular and physiologic effects of beta blockers in heart failure.

Sabbah HN.

Clin Cardiol. 1999 Oct;22 Suppl 5:V16-20. Review.

6.

Up-regulation of the cardiac lipid metabolism at the onset of heart failure.

Abdalla S, Fu X, Elzahwy SS, Klaetschke K, Streichert T, Quitterer U.

Cardiovasc Hematol Agents Med Chem. 2011 Jul 1;9(3):190-206. Review.

7.

Metabolic remodeling in hypertrophied and failing myocardium: a review.

Peterzan MA, Lygate CA, Neubauer S, Rider OJ.

Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H597-H616. doi: 10.1152/ajpheart.00731.2016. Epub 2017 Jun 23. Review.

PMID:
28646030
8.

Outline of proteins and signaling pathways involved in heart failure.

Bi Q.

Curr Protein Pept Sci. 2012 Nov;13(7):682-6. Review.

PMID:
23228350
9.

Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.

Hunter WG, Kelly JP, McGarrah RW 3rd, Kraus WE, Shah SH.

Curr Heart Fail Rep. 2016 Jun;13(3):119-31. doi: 10.1007/s11897-016-0289-5. Review.

10.

Metabolomics - A wide-open door to personalized treatment in chronic heart failure?

Marcinkiewicz-Siemion M, Ciborowski M, Kretowski A, Musial WJ, Kaminski KA.

Int J Cardiol. 2016 Sep 15;219:156-63. doi: 10.1016/j.ijcard.2016.06.022. Epub 2016 Jun 14. Review.

PMID:
27323342
11.

Inflammatory Biomarkers and Therapeutic Targets in Heart Failure.

Papadimitriou L, Kalogeropoulos AP.

Curr Med Chem. 2015;22(23):2716-26. Review.

PMID:
25876745
12.

Heart failure and loss of metabolic control.

Wang ZV, Li DL, Hill JA.

J Cardiovasc Pharmacol. 2014 Apr;63(4):302-13. doi: 10.1097/FJC.0000000000000054. Review.

13.

Genetics and epigenetics of arrhythmia and heart failure.

Duygu B, Poels EM, da Costa Martins PA.

Front Genet. 2013 Oct 30;4:219. doi: 10.3389/fgene.2013.00219. Review.

14.

Metabolic remodeling of substrate utilization during heart failure progression.

Chen L, Song J, Hu S.

Heart Fail Rev. 2018 May 23. doi: 10.1007/s10741-018-9713-0. [Epub ahead of print] Review.

PMID:
29789980
15.

The role of interleukin-1 in the failing heart.

Long CS.

Heart Fail Rev. 2001 Mar;6(2):81-94. Review.

PMID:
11309527
16.

Sizing up models of heart failure: Proteomics from flies to humans.

Kooij V, Venkatraman V, Tra J, Kirk JA, Rowell J, Blice-Baum A, Cammarato A, Van Eyk JE.

Proteomics Clin Appl. 2014 Oct;8(9-10):653-64. doi: 10.1002/prca.201300123. Epub 2014 Jun 25. Review.

17.

[Heart failure: the pathogenetic continuum and biomarkers].

Kharchenko EP.

Kardiologiia. 2012;52(3):53-64. Review. Russian.

PMID:
22839444

Supplemental Content

Support Center